The thymosin alpha 1 (Tα1) peptide is a naturally occurring peptide largely formed from the thymus gland. It has been hypothesized to play a significant role in the control of immunological responses.

Thymosin Alpha-1 (Tα1) is an endogenously occurring peptide originally isolated from thymic tissue, composed of 28 amino acids. It has emerged as a molecule of interest across various research domains ...

Hepatology, cancer, Immunology, and Neurology are just a few domains of research which have included research peptide Thymosin alpha-1 within the scope of their studies. Its relevance across a wide ...

Thymosin alpha 1, referred to as thymalfasin, is a synthetic 28-amino acid peptide with multiple biological activities primarily directed towards immune response enhancement. SciClone developed and ...

Gufic Biosciences Limited (Gufic) have received DCGI approval for Thymosin Alpha-1 (Immunocin α – A Brand of Gufic for the said drug) as an add-on therapy for the treatment of moderate-to-severe COVID ...

More than 30 medical practices and compounding pharmacies have made claims about the drug thymosin alpha-1 as a treatment for COVID-19 that are unproven, an NPR investigation found. The drug is not ...

This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.

Hepatitis C virus (HCV), a single-stranded RNA virus of the Flaviviridae family, is found worldwide. [3] Approximately 41% to 62% of HCV infections occur in patients who receive blood products, health ...